期刊
DIAGNOSTICS
卷 12, 期 9, 页码 -出版社
MDPI
DOI: 10.3390/diagnostics12092158
关键词
quantum dot; lateral flow immunoassay; infectious diseases
资金
- Higher Institution Centre of Excellence (HICoE), Ministry of Higher Education, Malaysia [311/CIPPM/4401005]
Infectious diseases are the leading cause of death worldwide. As the risk of emerging diseases increases, it is crucial to quickly diagnose infections and prevent further transmission. Current detection methods are time-consuming and less sensitive, while point-of-care testing offers the advantages of being rapid, user-friendly, and highly sensitive and specific. However, conventional detection methods still face the challenge of low sensitivity.
Infectious diseases are the world's greatest killers, accounting for millions of deaths worldwide annually, especially in low-income countries. As the risk of emerging infectious diseases is increasing, it is critical to rapidly diagnose infections in the early stages and prevent further transmission. However, current detection strategies are time-consuming and have exhibited low sensitivity. Numerous studies revealed the advantages of point-of-care testing, such as those which are rapid, user-friendly and have high sensitivity and specificity, and can be performed at a patient's bedside. The Lateral Flow Immunoassay (LFIA) is the most popular diagnostic assay that fulfills the POCT standards. However, conventional AuNPs-LFIAs are moderately sensitive, meaning that rapid detection remains a challenge. Here, we review quantum dot (QDs)-based LFIA for highly sensitive rapid diagnosis of infectious diseases. We briefly describe the principles of LFIA, strategies for applying QDs to enhance sensitivity, and the published performance of the QD-LFIA tested against several infectious diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据